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Abstract
Background: Improved understanding of lung cancer development and progression, including insights from studies of
animal models, are needed to combat this fatal disease. Previously, we found that mice with a knockout (KO) of G-protein
coupled receptor 5A (Gprc5a) develop lung tumors after a long latent period (12 to 24 months).
Methodology/Principal Findings: To determine whether a tobacco carcinogen will enhance tumorigenesis in this model,
we administered 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) i.p. to 2-months old Gprc5a-KO mice and sacrificed
groups (n=5) of mice at 6, 9, 12, and 18 months later. Compared to control Gprc5a-KO mice, NNK-treated mice developed
lung tumors at least 6 months earlier, exhibited 2- to 4-fold increased tumor incidence and multiplicity, and showed a
dramatic increase in lesion size. A gene expression signature, NNK-ADC, of differentially expressed genes derived by
transcriptome analysis of epithelial cell lines from normal lungs of Gprc5a-KO mice and from NNK-induced adenocarcinoma
was highly similar to differential expression patterns observed between normal and tumorigenic human lung cells. The
NNK-ADC expression signature also separated both mouse and human adenocarcinomas from adjacent normal lung tissues
based on publicly available microarray datasets. A key feature of the signature, up-regulation of Ube2c, Mcm2, and Fen1, was
validated in mouse normal lung and adenocarcinoma tissues and cells by immunohistochemistry and western blotting,
respectively.
Conclusions/Significance: Our findings demonstrate that lung tumorigenesis in the Gprc5a-KO mouse model is augmented
by NNK and that gene expression changes induced by tobacco carcinogen(s) may be conserved between mouse and
human lung epithelial cells. Further experimentation to prove the reliability of the Gprc5a knockout mouse model for the
study of tobacco-induced lung carcinogenesis is warranted.
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Introduction
It has been estimated that there will be nearly 220,000 new
cases and 160,000 deaths from lung cancer in the United States in
the year 2009 [1]. Non small-cell lung cancer (NSCLC) represents
the majority of lung cancers and includes two major histological
subtypes; squamous cell carcinomas and adenocarcinomas [2].
The incidence of the latter type is increasing globally and in the
United States [3,4]. In addition, nearly 85% of newly diagnosed
NSCLC patients are ever smokers clearly implicating tobacco and
tobacco-related carcinogens in the etiology of NSCLC [5].
Lung carcinogenesis occurs through a multi-step process, which
involves both, the activation or over-expression of oncogenes, and
the inactivation or suppression of tumor-suppressor genes [2].
Mouse models for human lung cancer have proven to be valuable
tools for understanding the basic tumor biology as well as for the
development and validation of new approaches to cancer
prevention and therapy [6]. While very few mouse strains exhibit
spontaneous lung tumor development, an increasing number of
models has been developed either by treatment with tobacco
carcinogens [7,8,9,10,11,12] or tobacco (or cigarette) smoke
[13,14,15] as well as by introduction of mutant oncogenes or
transgenes such as mutant Kras [16] or epidermal growth factor
receptor (Egfr) [17,18] or a combination of transgenes and
carcinogens [19]. We have previously shown that mice with
deletion of both alleles of the Gprc5a gene develop spontaneous
lung adenomas and adenocarcinomas between the ages 12 and 24
months indicating that this gene is a mouse lung-specific tumor
suppressor [20]. The Gprc5a knockout mouse was genetically
engineered using the C57BL/66129sv mixed background [20]. It
is noteworthy that mice of each of these two parental strains were
reported to be resistant to the carcinogenic effects of NNK [21,22]
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predisposed to develop spontaneous lung adenomas and to be
susceptible to NNK-induced lung tumorigenesis [11,23]. There-
fore, by analogy, we hypothesized that the knockout of Gprc5a,
which predisposes mice to spontaneous lung tumorigenesis [20]
will also sensitize them to a tobacco-specific carcinogen such as
NNK. In addition, given the pivotal role of tobacco use in the
etiology of human lung cancers [2,4], we thought that if a tobacco
carcinogen were to enhance lung tumorigenesis in the Gprc5a KO
mice, this model would be more relevant to the human disease.
In this study, we show that exposure of Gprc5a-knockout mice to
NNK tobacco-specific carcinogen increased the incidence and
multiplicity of lung tumors, especially adenocarcinoma, compared
to control mice. In addition, comparative functional genomics
approaches have enabled us to demonstrate that the gene expression
patterns signifying tobacco-carcinogen induced lung tumorigenesis
may be conserved between mouse and human lung epithelial cells.
Materials and Methods
Chemicals and reagents
The tobacco carcinogen NNK with a purity of greater than
99% was purchased from Midwest Research Institute (The
National Cancer Institute’s Chemical Carcinogen Reference
Standard Repository, Kansas City, MO). Mice were fed Purina
chow #5001 (Harlan-Teklad, Madison, WI). Hematoxylin and
Eosin staining reagents were purchased from DAKO (Carpinteria,
CA) and Sigma-Aldrich (St. Louis, MO), respectively.
NNK-induced tumorigenesis experimental design
We used (129sv6 C57BL/6) F1 Gprc5a knockout (Gprc5a
2/2)
mice, which were generated as described previously [20]. The mice
were maintained according to a protocol approved by the M.D.
Anderson Cancer Center Institutional Animal Care and Use
Committee at the institution’s specific pathogen-free animal facility,
which is approved by the American Association for Accreditation of
Laboratory Animal Care and is operated in accordance with
current regulations and standards of the US Department of
Agriculture and the Department of Health and Human Services.
Gprc5a knockout mice (2 months old) were divided into groups
of 5 or 6 mice and were injected twice (one week apart)
intraperitonealy with NNK (104 mg/kg of body weight) dissolved
in saline (0.9% NaCl) or with saline alone as control. Mice were
selected randomly at 6, 9, 12 and 18 months after the second
injection and sacrificed (Fig. 1A). The lungs were excised and
inflated by injection of formalin and lung surface lesions were
detected and enumerated by macroscopic observation. The lungs
were then embedded in paraffin and histological sections were
prepared and analyzed using standardized criteria [24] for
characterization and diagnosis of lung lesions by two experienced
pathologists (J.F. and C.V.P). The size of lung lesions was
measured and quantified by the Image J program developed by
the National Institutes of Health (rsbweb.nih.gov/ij/).
Gprc5a
2/2 normal epithelial cells and MDA-F471
NNK-induced adenocarcinoma cells
Epithelial cells were derived from tracheas of 3-weeks old
Gprc5a
2/2 mice [20] and MDA-F471 mouse lung adenocarcinoma
cells were derived denovo froman adenocarcinomathat wasfound in
the lung of a female Gprc5a-knockout mouse sacrificed 16 months
after NNK i.p. injection based on a protocol approved by the M.D.
Anderson Cancer Center Institutional Animal Care and Use
Committee. Normal tracheas and lung adenocarcinoma dissected
from the mice were excised, washed in antibiotic-containing
phosphate-buffered saline (PBS), cut into small fragments (1–
3m m
3) and suspended in a pre-warmed cell aggregate dissociation
solution containing protease, collagenolytic and DNase activities
(ACCUMAX
TM, Innovative Cell Technologies, San Diego, CA).
The tissue fragments were then incubated for 1 hour at 37uC with
occasional agitation and observation under the microscope to
assess the efficacy of tissue disaggregation. Cell viability was
assessed using the trypan blue dye exclusion method. Following
completedisaggregation,cellsweretransferred tosterile15 mltubes
and centrifuged at 3006 g to pellet the cells and remove the
ACCUMAX
TM solution. The pellets were then resuspended in
1m lo fA MNIOMAX
TM –C100 Basal Medium (GIBCO) containing
AMNIOMAX
TM –C100 Supplement (GIBCO). Cells were then
seeded in 60 mm PRIMARIA
TM tissue culture dishes (BD
Biosciences, San Jose, CA) and maintained in culture using
keratinocyte-serum-free medium (K-SFM) (GIBCO; Invitrogen,
Grand Island, NY) supplemented with EGF (5 ng/ml) and Bovine
pituitary extract (50 mg/ml) (GIBCO, Invitrogen) for the normal
cells or DMEM:F12 medium supplemented with 10% fetal bovine
serum for the MDA-F471 adenocarcinoma cells. The medium was
replaced every 48 hours. All cells were grown at 37uCi na
humidified atmosphere of 95% air and 5% CO2. The MDA-471
cellsweretumorigenicasevidencedbytheformationoftumorsafter
injection of cultured cells (4610
6 cells in 10% Matrigel in PBS)
subcutaneously into syngeneic mice. In contrast, the Gprc5a
2/2
normal lung epithelial cells isolated from normal tracheas were non-
tumorigenic but formed viable colonies in soft agar.
RNA extraction
Total RNA was purified from the MDA-F471 mouse adeno-
carcinoma cells using the RNeasy Mini kit according to the
Figure 1. NNK-induced lung carcinogenesis in Gprc5a-knockout mice. Schematic illustration depicting the experimental plan where 2
months old Gprc5a-knockout mice were treated with 104 mg/kg body weight NNK or control saline intraperitonealy (i.p.) twice one week apart and
followed up for lung lesion development at 6, 9, 12 and 18 months following treatment.
doi:10.1371/journal.pone.0011847.g001
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was treated with DNase to eliminate genomic DNA. Purified total
RNA was then quantified using the Nanodrop ND-1000H
spectrophotometer (Thermo Fisher Scientific, Waltham, MA).
RNA quality was assessed based on the 28S/18S ribosomal RNAs
ratio using the Experion automated electrophoresis system (Bio-
Rad Laboratories, Hercules, CA) according to the manufacturer’s
instructions.
Microarray sample preparation, hybridization, scanning,
and analysis
Double-stranded cDNA was synthesized with the Superscript
Choice system (Invitrogen) using 5 mg of total RNA, isolated from
the Gprc5a
2/2 MDA-F471 cells, for each strand and cleaned by
phenol/chloroform extraction and ethanol precipitation. Biotin-
labeled cRNAs were then synthesized by in vitro transcription (IVT)
reaction using the ENZO BioArray High Yield RNA transcript
labeling kit (Affymetrix, Santa Clara, CA). After cleanup of cRNA
using RNeasy spin columns (Qiagen), fragmented cRNAs were
hybridized to GeneChipH Mouse Genome 430 2.0 arrays
(Affymetrix) according to the manufacturer’s instructions. The
arrays were scanned with a GeneChipH Scanner 3000 from
Affymetrix and raw image files were converted to probe set data
(*.CEL files) using the Affymetrix GeneChipH Operating Software.
Expression microarray data are MIAME compliant. Raw micro-
array data have been similarly previously generated for the normal
Gprc5a
2/2 lung cells (Kadara et al, in press).
Raw microarray data files (*.CEL) representing the transcrip-
tomes of the Gprc5a
2/2 normal and MDA-F471 adenocarcinoma
cells were imported and analyzed using the BRB-ArrayTools
v.3.7.0 developed by Dr. Richard Simon and BRB-ArrayTools
Development Team [25]. Robust multi-array analysis (RMA) was
used for normalization of gene expression data using the R
language environment [26]. An NNK-ADC (NNK-induced
adenocarcinoma) signature was derived which was comprised of
gene features that were differentially expressed between the mouse
normal Gprc5a
2/2 cells and MDA-F471 adenocarcinoma cells.
The gene features were selected based on the criteria of a p-
value,0.001 of a random variance two-sample t-test with
permutation and estimation of the false discovery rate and a 2-
fold difference in expression. The NNK-ADC signature was also
analyzed using Ingenuity Pathways Analysis (IPAH) (http://www.
ingenuity.com) to organize the gene features into molecular gene
sets and pathways significantly modulated between the Gprc5a-
knockout normal and NNK-induced adenocarcinoma cells.
The NNK-ADC signature derived from Gprc5a
2/2 and MDA-
F71 cells constituting lung carcinogenesis in the Gprc5a knockout
mouse were directly integrated with previously characterized
differentially expressed genes (GSE accession #17073) [27]
between normal human bronchial epithelial (NHBE) cells and
lung tumorigenic 1170-I cells. The tumorigenic cells were derived
from a tumor that had developed in nude mice after transplan-
tation of an immortalized cell line derived from NHBE cells and
exposed to cigarette smoke condensate in vivo [28]. Only
orthologous genes present in both mouse and human microarray
data and differentially expressed by at least 2-fold between the
human NHBE and 1170-I cells (n=523) (Table S1) were
integrated for cluster analysis and functionally analyzed using
IPAH. To assess the expression of the NNK-ADC expression
signature in human NSCLC compared to normal lung specimens,
we integrated unique orthologous members of the mouse gene
signature with published human gene expression data from the
reports by Su et al (27 lung adenocarcinomas and paired adjacent
normal lung) [29] and Stearman et al. (20 lung adenocarcinomas
and 19 adjacent normal lung; from 10 patients in replicate) [30].
The NNK-ADC signature was also integrated with gene
expression data of mouse normal lung (n=15) and adenocarci-
noma (n=29) tissue [30] also available from the study by
Stearman et al. Raw microarray data from all data sets were
analyzed using the BRB-ArrayTools and gene expression data
were normalized by RMA. Prior to integration of the NNK-ADC
signature with the mouse and human lung cancer data sets, unique
orthologous genes and probe sets present in Affymetrix Gene-
ChipH Mouse Genome430 2.0 and the mouse Affymetrix MG-
U74Av2 and human Affymetrix HG-U95Av2 and HG-U133A
platforms were identified using NetAffx
TM from Affymetrix
(http://www.affymetrix.com/analysis/index.affx) by searching
for orthologous members with their corresponding gene annota-
tions in the platforms. We found 2475 common orthologs of the
NNK-ADC gene signature in the U133A dataset from the study
by Su et al., and 1877 orthologs and 1452 gene features present in
the human HG-U95Av2 and mouse MG-U74Av2 datasets,
respectively, obtained from the study by Stearman et al.
Hierarchical cluster analysis by average linkage was performed
with Cluster 2.11, and results were visualized with TreeView
programs (Michael Eisen Laboratory, Lawrence Berkeley National
Laboratory and University of California, Berkeley; http://rana.lbl.
gov/EisenSoftware.htm). Principal component analysis (PCA) in
three-dimensional space was also performed using the BRB-
ArrayTools software using metric centered correlation.
Hematoxylin-Eosin (H&E) staining and
Immunohistochemistry analysis
Formalin-fixed paraffin-embedded tissue samples were used to
prepare 5 mm thick sections. Some sections were stained with
Hematoxylin and eosin (H&E) and used for microscopic observa-
tion. Other sections were mounted on poly-L-lysine-coated slides
and used for immunohistochemical analysis with antibodies against
mouse ubiquitin-conjugating enzyme E2C (Ube2c) (Boston Bio-
chem, Cambridge, MA), flap-like endonuclease 1 (Fen1) (Novus
Biologicals, Litteleton, CO), minichromosome maintenance 2
(Mcm2) (Cell Signaling Technology, Danvers, MA), and cyclin
D1 (Ccnd1) (Cell MarqueRocklin CA). The sections were subjected
to antigen retrieval (Target Retrieval Solution, DAKO), and then
incubated in peroxidase blocking reagent (DAKO). Sections were
then washed with Tris-containing buffer and incubated overnight at
4uC with the primary antibodies. Subsequently, the sections were
washed and incubated with the secondary antibody (goat anti-
rabbit) using the Evision plus labeled polymer kit (DAKO) for
30 min followed by incubation with avidin-biotin-peroxidase
complex (DAKO) and development with diaminobenzidine chro-
mogen for 5 min. Finally, the sections were rinsed in distilled water,
counterstained with hematoxylin (DAKO), and mounted on glass
slides before evaluation under the microscope. Immunohistochem-
ical analysis of the staining reactivity of the abovementioned
markers were done in triplicate on three different histological
sections of normal lung or NNK-induced adenocarcinomas. The
staining intensities for each antigen were quantified by counting the
number of cells exhibiting positive reactivity in up to three
microscopic fields per tumor or normal lung in five different
Gprc5a
2/2 mice injected i.p. with NNK. The mean levels of the
markers’ immunoreactivity were then statistically assessed for
significance of differences by the Students t-test. P-values less than
0.05 were considered statistically significant.
Western blotting analysis
Cell monolayers were washed twice with ice-cold PBS,
harvested, and processed for western blotting as previously
NNK-Induced Lung Carcinomas
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Ube2c (Boston Biochem.), Fen1 (B.D. Pharmingen San Diego
CA), Mcm2 and cyclin D1 (Cell Signaling Technology), and beta-
actin (Sigma Chemical Co.). Antibody binding was detected by the
standard enhanced chemiluminescence system. Membranes were
stained with beta-actin to ensure equality of protein loading and
transfer.
Results
NNK exposure increases incidence and multiplicity of
lung tumors in Gprc5a-knockout mice
The long time required for the development of tumors in the
Gprc5a
2/2 mouse model as well as the low tumor multiplicity had
prompted us to determine whether the tobacco carcinogen NNK
might enhance lung carcinogenesis in this model. To address this
question, we adopted a protocol developed for the A/J mouse
model [8,9,12], namely 2 months old mice (n=42) received two
weekly-spaced i.p. injections of NNK or saline and groups of 5–6
mice each were sacrificed at 6 to 18 months following NNK
injection (Fig. 1). Lung lesions were first detected in control mice
only 18 months after i.p. injection of saline with one mouse
developing an adenoma and another animal an adenocarcinoma.
In sharp contrast, lung tumors were detected in 25% of carcinogen
exposed mice after as early as 6 months (Fig. 2, left panels). The
incidence of tumors increased with time in the NNK-treated
Gprc5a
2/2 mice reaching 50% and 83% for adenomas and
adenocarcinomas, respectively at 18 months compared to 16.7%
and 16.7%, respectively in the control mice (Fig. 2). Furthermore,
NNK increased the multiplicity of both adenomas and adenocar-
cinomas compared to control mice (Fig. 2, right panels).
Assessment of the effects of NNK exposure on total lung lesions’
incidence and multiplicity at the longest time period (18 months)
revealed 2.5-fold and 4-fold increases, respectively (Fig. 2 upper
panels). No lesions were detected in other organs. These findings
indicate that exposure of Gprc5a
2/2 mice to NNK accelerated the
development of lung lesions and increased their incidence and
number.
Characterization of lung lesions in NNK-exposed and
control Gprc5a-knockout mice
Visual inspection of the lungs clearly revealed that the lesions in
mice sacrificed 18 months after NNK were much larger than in
controls (Fig. 3A, upper panels). Histological sections of FFPE
whole lungs revealed this characteristic also for internal lesions
(Fig. 3A, lower panels). We calculated the percent of total lung
Figure 2. Increased incidence and multiplicity of lung tumors in Gprc5a-knockout mice exposed to NNK compared to control mice.
Graphs depicting the percentage of mice with lung tumors (left panels) and number of tumors per mouse as a measure of multiplicity (right panels)
in the control (orange line) and NNK-exposed (black line) groups at 6, 9, 12 and 18 months following injection with the carcinogen.
doi:10.1371/journal.pone.0011847.g002
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burden of adenocarcinoma lesions in NNK-exposed mice was
variable (1.38 to 41.4%) and that of adenoma ranged from 0 to
3.21% (Fig. 3B). In the control mice, where only one adenocar-
cinoma and one adenoma were found after 18 months, the tumor
burdens were 0.73 and 0.07%, respectively.
The diagnosis of individual lesions as adenoma or adenocarci-
noma was accomplished after analysis of H&E stained tissue
sections of lungs from control and NNK-exposed mice under the
microscope and examples of such lesions are presented in Fig. 4.
The adenoma and adenocarcinomas lesions from lungs of NNK-
exposed mice were composed of cells appearing less differentiated
and with higher nuclear crowding and cytological atypia than cells
in the corresponding lesions of control mice (Fig. 4). These findings
suggested that NNK exposure leads to the development of more
aggressive lung tumors compared to control Gprc5a
2/2 mice.
Identification of differential gene expression patterns
and functional cellular pathways between epithelial cell
lines derived from normal lungs of Gprc5a
2/2 mice and
from adenocarcinomas of NNK-exposed mice
To begin to understand the mechanism(s) underlying the above
effects of NNK, we decided to compare and contrast global gene
expression in lung epithelial cells isolated from Gprc5a
2/2 mouse
trachea and in MDA-F471 tumor cells cultured from an
adenocarcinoma from an NNK-exposed Gprc5a
2/2 mouse. We
derived a gene expression signature signifying differentially
expressed gene features between the cell types, NNK-ADC
signature. Differentially expressed gene features (n=4981) were
selected based on the criteria of a p,0.001 of the univariate t-test
with permutation and estimation of the false-discovery rate and a
change in expression of at least 2-fold. Functional analysis of the
Figure 3. Increased lung tumor burden in NNK-exposed Gprc5a-knockout mice. A.Gross and macroscopic images representing total lungs
excised from two mice each injected i.p with control saline (left) or NNK (right). Arrows indicate gross lung images representing selected H& E stained
histological sections of total lungs from both groups and arrowheads indicate presence of a lung tumor (adenomas, 1; adenocarcinomas, 2). B. Lung
tumor areas were quantified by Image-J software to assess tumor burden displayed in the graph as percentage occupied of total area.
doi:10.1371/journal.pone.0011847.g003
NNK-Induced Lung Carcinomas
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(significance indicated as 2log of the p-values) modulation of
several cancer-related molecular function-specific gene sets such as
cell death, cell growth and proliferation and cell cycle (all
p,0.001) (Fig. 5A, left panel). Moreover, functional analysis
revealed canonical cellular pathways that are differentially
activated between the adenocarcinoma cells and the normal lung
epithelial cells. These pathways included p53 and vascular
endothelial growth factor (Vegf ) signaling pathways and cell cycle
G2/M and G1/S checkpoints (all p,0.001) (Fig. 5A, right panel).
Differential gene expression patterns between Gprc5a-
knockout MDA-F471 adenocarcinoma and normal lung
cells closely mimic those in an in vitro model of human
lung carcinogenesis
To assess the relevance of the findings with the murine normal
and NNK-induced tumor cells to human lung carcinogenesis, we
compared their differential expression patterns to those of a
comparable in vitro pair of human normal and tobacco-induced
tumorigenic lung cells (NHBE and 1170-I, respectively) (refer to
Materials and Methods section). Orthologous members of the
NNK-ADC signature that were present both in the Affymetrix
human genome (HG) U133A and Mouse Genome 430 2.0
platforms and differentially expressed between the NHBE and
1170-I cells (GSE# 17073, [27]) were directly compared and
integrated in the mouse and human systems (n=523). Hierarchi-
cal cluster analysis of the integrated data revealed that two gene
clusters with similar patterns of differential expression between the
mouse and human adenocarcinoma and normal cells (gene cluster
1, red; gene cluster 3, green) (Fig.5B). Although, most genes
(81.5%) displayed concordant expression between the mouse and
human in vitro carcinogenesis systems (Fig. 5B), we observed two
clusters of genes with reverse expression in the mouse and human
cells; the second and fourth (from the top) gene clusters were
comprised of 18 (3.5%) and 84 (16%) genes, respectively, (Fig. 5B).
Furthermore, following principal component analysis in three-
dimensional space, the mouse MDA-F471 adenocarcinoma cells
resided very closely to the human lung 1170-I tumorigenic cells
which together were distant from the mouse Gprc5a
2/2 normal
lung epithelial cells and the human NHBE cells (Fig. 5C). These
data demonstrate that gene expression patterns may be conserved
between cells in NNK-induced lung carcinogenesis in the Gprc5a-
knockout mouse and cells constituting an experimental model of
human lung carcinogenesis.
Notably, in both mouse and human carcinogenesis systems, we
observed similar differential expression patterns of genes that had
been previously characterized by functional pathways analysis in
the same human in vitro model of lung carcinogenesis [27], namely,
Ube2c, Mcm2 and Fen1 (Fig. 5B, lower right panel). Functional
pathways analysis using the IPAH software revealed significant
modulation of neighborhood and network gene modules sur-
rounding the Mcm2 and Fen1 genes in the Gprc5a
2/2 adenocar-
cinoma (Fig. 6, top and bottom, respectively). The expression
levels of Mcm2 and several related Mcm genes such as Mcms 3, 4, 5,
6, 7 and 10, as well as Fen1 were increased (indicated by the red
color) in the depicted gene-interaction networks. These findings
highlighted genes, e.g. Fen1 and Mcm2, that are predicted to be
important in the development of adenocarcinomas in Gprc5a-
knockout mice exposed to NNK through both their modulation in
expression and number and significance of molecular interactions.
Up-regulation of Ube2c, Mcm2, Fen1 and cyclin D1
proteins in lung adenocarcinoma tissue and cells
compared to normal lung in NNK-exposed Gprc5a-
knockout mice
Because gene expression at the mRNA level does not always
correspond to protein levels, we then examined the expression of
the protein products of Ube2c, Fen1 and Mcm2 in Gprc5a
2/2 lung
normal and adenocarcinoma tissue and cells. We also assessed the
protein levels of the cell cycle marker, cyclin D1 in the same tissue
and cells because it was up-regulated in the MDA-F471 cells at the
mRNA level and was previously shown to display intensive
expression in lung adenomas and adenocarcinomas from mice
exposed to NNK [10]. Immunohistochemical analysis demon-
strated the up-regulation of the protein levels of Mcm2, Fen1,
Ube2C and cyclin D1 in lung adenocarcinoma tissue of NNK-
exposed Gprc5a-knockout mice compared to the levels in normal
lung tissue obtained from the same mice (Fig. 7A). The mean levels
of the immunoreactivity of were all statistically significantly higher
in lung adenocarcinoma relative to normal lung tissue in the
NNK-exposed mice (p,0.001, *) (Fig. 7B). In accordance, Mcm2,
Fen1, Ube2c and cyclin D1 proteins were also relatively higher in
the MDA-F471 mouse adenocarcinoma cells compared to the
normal Gprc5a
2/2 cells as revealed by the western blotting analysis
(Fig. 7C). These results demonstrate that there is a concordance
between the mRNA and protein up-regulation of the above
markers when comparing both tumor and normal cells and tissues.
Integrated cluster analysis using the NNK-ADC
expression signature effectively separates mouse and
human NSCLC tissue from normal lung
We sought to test the relevance of the differential gene
expression patterns between the Gprc5a-knockout MDA-F471
adenocarcinoma and normal lung epithelial cells to the gene
expression patterns in publicly available microarray datasets of
both mouse and human NSCLC and normal lung tissue. We
analyzed the NNK-ADC signature in the expression data of
mouse lung adenocarcinomas (n=29) and adjacent normal lung
samples (n=15) from the study by Stearman et al [30].
Hierarchical clustering analysis of the data revealed that the
NNK-ADC signature effectively separated mouse normal lung
tissues from tumors indicating that the NNK-ADC signature was
highly associated with mouse adenocarcinomas (Fig. 8A). By using
only orthologous genes present in both mouse and human
microarray platforms, the NNK-ADC signature was also integrat-
ed with gene expression data of human lung adenocarcinomas and
adjacent normal counterparts available from previous studies
[29,30]. Hierarchical clustering analysis of the data revealed that
the signature was highly expressed in human tumors as it
effectively human lung adenocarcinomas from normal lung tissues
(Figs. 8B and 8C). Moreover, PCA analysis of all integrated
analyses revealed that lung adenocarcinomas lay considerably
distant from normal lung in three-dimensional space (Figs. 8A, 8B
and 8C). In addition, the differences in the number of lung
adenocarcinomas and normal lung tissues between the two
identified clusters were all statistically significant (p,0.001 by
Figure 4. Lung tumors in NNK-exposed Gprc5a-knockout mice display increased features of poor differentiation. Representative
photomicrographs of tissue histological sections following H&E staining of spontaneous adenomas and adenocarcinomas obtained from control
mice (A) and from Gprc5a-knockout mice exposed to NNK (B). Bars, 100 microns.
doi:10.1371/journal.pone.0011847.g004
NNK-Induced Lung Carcinomas
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expression patterns between Gprc5a-knockout NNK-exposed
MDA-F471 adenocarcinoma and normal lung cells may resemble
lung tumor molecular profiles in other mouse models of lung
carcinogenesis (e.g., urethane-exposed A/J mice, [30]) and in
human lung adenocarcinomas.
Discussion
Previously, we have identified the Gprc5a gene as a mouse lung-
specific tumor suppressor after finding that mice lacking both
alleles of this gene develop spontaneous lung adenomas and
adenocarcinomas unlike their wild-type littermates. Tumor
development in this model was preceded by a long latency period
of up to 24 months [20]. Given that most human lung cancers
(80%) occur in ever smokers [2,4,5], we thought that it might be
valuable to investigate the effects of exposure of Gprc5a-knockout
mice to a tobacco-specific carcinogen such as NNK. In this study
we found that exposure of young mice to NNK (only two i.p.
injections separated by one week) shortened the time to tumor
development and increased the incidence, multiplicity, and size of
both adenomas and adenocarcinomas in Gprc5a-knockout mice
compared to control mice. In this design, the exposure of mice to
the lung specific carcinogen occurs early in life suggesting that the
model mimics events that can be expected to occur in former
smokers. We based the design of the study with the Gprc5a-
knockout mice on previous studies with strain A/J mice [8,9,12],
which also have a predisposition for spontaneous lung tumors [11]
and exhibit enhanced carcinogenesis after i.p. injection of NNK
[11]. Our model is distinct from the A/J model in that our mice
have a defined genetic lesion, namely loss of Gprc5a [20], whereas
the genetic lesion in A/J mice is not fully defined. Interestingly, a
pulmonary adenoma susceptibility 1 (Pas1) locus has been found in
A/J mice on chromosome 6. This locus was found to include two
genes, Kras2 (Kirsten rat sarcoma oncogene 2) and Casc1 (cancer
susceptibility candidate 1), that are strong candidates for mediating
the predisposition to adenoma in the A/J mice [32]. It is
noteworthy that the Gprc5a gene is also located on mouse
chromosome 6 (G1), however, it is located 10 Kb away from the
Kras2 gene and is not encompassed within the Pas1 locus.
The exposure to NNK shortened the time to tumor develop-
ment and markedly increased the incidence and burden of
adenocarcinomas. In our study, the tumor burden among the five
mice sacrificed at the 18 month time point was variable, however,
even the smallest adenocarcinoma among the NNK-exposed mice
was larger than the single spontaneous adenocarcinoma. The
incidence of adenocarcinomas in the NNK exposed Gprc5a
knockout mice (80%) was much higher than the 17% incidence
of spontaneous adenocarcinomas in mice followed for up to 24
months [20] and also higher than that reported previously by
others for NNK-treated A/J mice [33]. A histological examination
of features of the spontaneous adenoma and adenocarcinoma and
their comparison to the corresponding NNK-induced tumors
indicated that the tumors induced by the tobacco carcinogen
appear to be less differentiated and more aggressive. However, it is
not possible to draw statistically significant conclusions about the
differential tumor histology because we only observed one
spontaneous adenoma and one spontaneous adenocarcinoma in
the control mice compared to numerous tumors in the NNK
group. Nonetheless, our model is relevant to human lung cancer
because the incidence of adenocarcinoma among human patients
is increasing relative to squamous cell carcinomas [4]. The
development of adenocarcinomas at the exclusion of squamous
cell carcinomas is characteristic of other mouse lung carcinogen-
esis models including NNK-treated A/J strain mice [9,12,23] and
mutant Kras transgenic mice [16]. In future studies, it would be
worthwhile to investigate the tumor incidence of Gprc5a knockout
mice exposed to varying and increases doses of NNK.
To begin to understand the molecular mechanisms underlying
the development of adenocarcinomas in NNK-exposed Gprc5a-
knockout mice, we used microarray profiling, to compare and
contrast the transcriptomes of MDA-F471 malignant cell line
and normal lung epithelial cells isolated from NNK-exposed
Gprc5a
2/2 mice and from normal tracheas of untreated Gprc5a
2/2
mice, respectively. This comparison led us to derive a gene
expression signature, which we named NNK-ADC signature that
is comprised of genes differentially expressed between the mouse
adenocarcinoma and normal cells. Upon functional pathways
analysis, these genes were organized into significantly differentially
activated prominent cancer-related pathways such as G1/S and
G2/M cell cycle checkpoints and cell growth and proliferation.
The perturbation of such cellular pathways may explain the
enhanced carcinogenesis in NNK-exposed Gprc5a
2/2 mice as cell
cycle promoting genes have been implicated in NNK-mediated
tumorigenesis in A/J strain mice [10].
Comparative genomic approaches have shown promise to
highlight mouse models reliably mirroring the corresponding
human disease [34,35] and to unravel evolutionarily conserved
and important genes [36]. A pertinent question is whether the
differential gene expression patterns between the Gprc5a
2/2
adenocarcinoma MDA-F471 cells and the normal lung Gprc5a
2/2
cells are relevant to human lung carcinogenesis. To explore this
question, we first integrated orthologous features of the NNK-
ADC signature derived herein with previously characterized
genes, which we had found recently to be differentially expressed
[27] between human normal (NHBE) and tumorigenic (1170-I)
cells. Our integrated cluster analysis revealed a substantial overlap
between both pairs of normal and malignant cells with most genes
differentially expressed in a similar pattern in both mouse and
human mRNA profiles. Further use of comparative genomic
approaches and integrating the NNK-ADC signature in published
microarray data sets of both mouse and human normal lung and
adenocarcinoma tissue, the signature was found to effectively
discriminate lung tumor tissues from their adjacent normal
Figure 5. The mouse NNK-ADC signature exhibits significant modulation of cancer-related gene sets and pathways that are similar
in an in vitro model of human lung carcinogenesis. A. The mouse NNK-ADC signature comprising 4981 gene feature differentially expressed
between Gprc5a-knockout MDA-F471 adenocarcinoma cells and Gprc5a
2/2 normal lung cells normal cells was derived based on selection criteria
described in the Methods. The signature was functionally analyzed using global functional categories from by IPAH. The value of 2log(significance)
represents the inverse log of the p-values of the modulation of the depicted functional categories (left panel) and pathways (right panel) between the
mouse normal and adenocarcinoma cells. The number of genes displaying more than 2 fold change is indicated above each bar. B. Human orthologs
of the mouse NNK-ADC and also differentially expressed between the human lung tumorigenic 1170-I and normal NHBE cells (n=523) were median-
centered independently in the mouse and human lung epithelial cells, integrated and then analyzed by hierarchical cluster analysis. High or low gene
expression levels are indicated by red or green color, respectively as indicated by the log2 transformed scale bar. Gene clusters are numbered 1 to 4.
The clusters of up-regulated and down-regulated genes are highlighted in red and green, respectively. C. PCA analysis in three-dimensional space of
the integrated data using metric centered correlation.
doi:10.1371/journal.pone.0011847.g005
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PLoS ONE | www.plosone.org 10 July 2010 | Volume 5 | Issue 7 | e11847counterparts. These data demonstrate that the differential gene
expression patterns between Gprc5a-knockout NNK-induced lung
adenocarcinoma and normal epithelial cells may be conserved
between mouse and human lung epithelial cells.
Using comparative functional genomics and functional path-
ways analysis followed by validation at the protein level by
immunohistochemistry and western blotting analyses, we high-
lighted the marked up-regulation of Ube2c, Mcm2 and Fen1 in
Gprc5a-knockout mouse adenocarcinoma relative to normal lung.
Interestingly, the expression of these genes has been linked to
human lung cancer. UBE2C, a ubiquitin conjugating enzyme, is
important for lung cancer cell survival [37] and was previously
shown by our group to increase in expression progressively in lung
lesions [27]. MCM2 is a component of the minichromosome
maintenance complex that was demonstrated to be highly
expressed in human NSCLC as well as in preneoplastic lesions
[38,39]. The flap structure-specific endonuclease, FEN1, was
reported to exhibit elevated expression in human NSCLC cells
compared to normal human bronchial epithelial cells [40]. It is
noteworthy that we have previously demonstrated the progressive
and significant modulation of the mRNA levels of UBE2C, MCM2
and FEN1 in normal, immortalized, transformed and tumorigenic
Figure 6. Gene-interaction network analysis of genes differentially expressed between both mouse and human normal lung
epithelial and adenocarcinoma cells. IPAH analysis of gene-interaction networks and neighborhoods involving the selected genes, Mcm2 (top)
and Fen1 (bottom), differentially expressed between Gprc5a
2/2 normal lung cells and adenocarcinomas as well as between human normal NHBE cells
and 1170-I tumorigenic cells (highlighted in inlet of 5B). Interaction nodes of the Mcm2 and Fen1 genes are highlighted by a blue border. Gene
expression variation by at least 2-fold is depicted by color (red, up-regulated; green, down-regulated).
doi:10.1371/journal.pone.0011847.g006
Figure 7. Elevated expression of Ube2c, Mcm2, Fen1 and cyclin D1 proteins in Gprc5a-knockout adenocarcinomas and normal lung
tissue and cells. A. Representative photomicrographs depicting increased expression of the protein products of Mcm2, Ube2c, Fen1 and cyclin D1
in NNK-induced adenocarcinomas and normal lung histological tissue specimens obtained from NNK-exposed Gprc5a-knockout mice. All four
proteins exhibited mainly nuclear localization of expression. B. The number of cells exhibiting positive reactivity (nuclear staining) was counted in up
to three separate microscopic fields per tumor or normal lung in five different NNK-exposed Gprc5a
2/2 mice. P-values were obtained by the students
two-sample t-test (*, p,0.001). C. Western blotting analysis of the four antigens in three different culture dishes of each of the Gprc5a
2/2 MDA-F471
adenocarcinoma and normal lung cells. Approximately 10
6 cells per 10 cm cell culture dish were harvested to prepare total protein extracts. Samples
of these extracts (20 mg protein) were analyzed by western blotting using primary antibodies against the indicated proteins. Membrane blots were
also analyzed with antibodies against b-actin to compare protein loading in the different lanes.
doi:10.1371/journal.pone.0011847.g007
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carcinogenesis [27]. Moreover, the transformed and tumorigenic
derivatives of this human in vitro model were generated following
exposure of xenotransplants of BEAS-2B cells (derived from
NHBE cells immortalized with the large T antigen of SV40) to
another tobacco-related carcinogen, cigarette smoke condensate
[28]. Therefore, it is plausible to suggest that the association of
expression of UBE2C, MCM2 and FEN1 with tobacco-induced
lung carcinogenesis appears to be evolutionarily conserved.
Indeed, we have previously unraveled a robust association
between UBE2C protein expression and smoking habits or
patterns in histological tissue specimens obtained from approxi-
mately 300 NSCLC patients [27]. These findings evoke the
possibility that the characterized NNK-ADC signature signifying
molecular differences between the Gprc5a-knockout NNK-induced
adenocarcinoma and normal lung cells may be valuable in the
discovery of genes that are relevant to tobacco-induced human
lung cancer cells.
Although we had been able to isolate only a single pair of
Gprc5a
2/2 normal lung epithelial cells and lung adenocarcinoma
cells from an NNK-exposed mouse, we were successful in deriving
an NNK-ADC expression signature. We recognize that using an
expression signature signifying lung adenocarcinoma development
in the NNK-exposed Gprc5a knockout mouse model based on a
single pair or normal and tumor cells and without a complimen-
tary set of data from another pair of samples represents a potential
limitation. However, it is important to mention that when we
integrated the genes differentially expressed between the mouse
Gprc5a
2/2 normal and MDA-F471 tumor cells with those
modulated between human normal and tumorigenic lung cells,
most (81.5%) exhibited concordant expression between the in vitro
carcinogenesis systems from both species. Moreover, the protein
expression of several key genes of the NNK-ADC signature was
validated at the protein level by immunohistochemistry in
histological tissue specimens of normal lung and adenocarcinomas
obtained from five Gprc5a knockout mice. Furthermore, the NNK-
ADC expression signature was analyzed in publicly available
datasets and was found to effectively separate human lung
adenocarcinomas from normal lung tissues. Therefore, it is likely
that gene expression patterns in the NNK-exposed Gprc5a
Figure 8. The mouse NNK-ADC expression signature effectively separates both mouse and human lung adenocarcinomas from
their adjacent normal counterparts. A. Dendogram (left) of hierarchical cluster analysis and PCA (right) of the gene features (n=1452) of the
NNK-ADC signature that are present in the Affymetrix MG-U74Av2 platform and gene expression data of mouse normal lung (n=15) and
adenocarcinoma (n=29) tissue from the study by Stearman et al [30]. Dendograms (left) of hierarchical cluster analysis and PCA (right) of human
datasets including 20 lung adenocarcinomas and 19 adjacent normal lung samples from the study by Stearman et al (B) and 27 lung
adenocarcinomas and 27 paired adjacent normal lung from the study by Su et al [29] (C) and using only orthologous genes of the signature and
found in the Affymetrix MG-U95Av2 (B, n=1877) and HG-U133A (C, n=2475) platforms.
doi:10.1371/journal.pone.0011847.g008
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lung cancer epithelial cells.
In conclusion, we have found that treatment of Gprc5a-knockout
mice with the tobacco-specific carcinogen NNK increased the rate
of lung adenocarcinoma development compared to the spontane-
ous rate in control mice. Moreover, we were able to highlight
genes potentially important for NNK-induced lung carcinogenesis
in the Gprc5a-knockout mouse. We also provide evidence that
suggests that differential gene expression patterns in NNK-induced
lung carcinogenesis in the Gprc5a-knockout mouse cells may be
conserved in human lung cancer epithelial cells. Further
experimentation is warranted to validate the reliability of the
NNK-exposed Gprc5a-knockout mouse for the study of tobacco
carcinogen(s)-induced lung tumorigenesis and for use in future
chemoprevention studies.
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